AWM
LCTX icon

Avior Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Avior Wealth Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-300
Closed -$150 – 1633
2024
Q4 		$150 Hold
300
– – ﹤0.01% 2391
2024
Q3 		$271 Hold
300
– – ﹤0.01% 2210
2024
Q2 		$299 Sell
300
-21
-7% -$23 ﹤0.01% 2162
2024
Q1 		$475 Buy
321
+21
+7% +$24 ﹤0.01% 2582
2023
Q4 		$327 Hold
300
– – ﹤0.01% 1451
2023
Q3 		$354 Hold
300
– – ﹤0.01% 1520
2023
Q2 		$423 Hold
300
– – ﹤0.01% 1474
2023
Q1 		$450 Buy
+300
New +$419 ﹤0.01% 1528

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return